Latest News

Monday, October 15, 2018

Krystal Biotech: Positive Interim Results in Phase 1/2 Trial of KB103

Krystal Biotech, Inc. has announced positive interim results from its ongoing placebo-controlled Phase 1/2 clinical trial of KB103. Two adult Recessive Dystrophic Epidermolysis Bullosa (“RDEB…

Read the full story

Monday, October 15, 2018

Lumenis Introduces SPLENDOR X, New Laser Hair Removal Solution

Lumenis Ltd. has launched SPLENDOR X, the first solid state laser system equipped with the unique BLEND X technology for fast and effective hair removal and skin solutions. The technology was showcase…

Read the full story

Monday, October 15, 2018

Music City SCALE: Registration Open; New Website Launches

Registration is now open for Music City Scale on the meeting's newly redesigned website. The website features new details about the meeting, scheduled May 9-11, 2019 at Music City Center in Nashvi…

Read the full story

Thursday, October 11, 2018

ASDS Announces 2018 President’s Award Recipients

In her final act as president this week, Lisa M. Donofrio, MD, recognizes four members of the American Society for Dermatologic Surgery (ASDS) with the President’s Award at the Society’s A…

Read the full story

Thursday, October 11, 2018

Cellulite Reduction Seen With Cellfina Lasts Five Years

One Cellfina treatment improves the appearance of cellulite on the thighs and buttocks for five years, according to new data presented by Merz at the Annual Meeting of the American Society for Dermato…

Read the full story

Thursday, October 11, 2018

Pre-conditioning Added to Sebacia Microparticles Enhances Outcomes

Using pre-conditioning in conjunction with Sebacia Microparticles for treatment of acne leads to enhanced outcomes, new data suggest. In fact, results from a real-world, pre-conditioning registry tria…

Read the full story

Thursday, October 11, 2018

Endo Presents Data on the Perception and Measurement of Cellulite Severity at ASDS Meeting

The new Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) is a reliable tool for evaluating cellulite severity of the buttocks and thighs and correlates well with the Patient Reported…

Read the full story

Thursday, October 11, 2018

Study: Positive Safety and Tolerability Results for Ortho Dermatologics' Altreno for Acne

Ortho Dermatologics shared results of two identical Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel group studies examining the efficacy and safety of Altreno (tretinoin) …

Read the full story

Thursday, October 11, 2018

Galderma Ups Its Aesthetic R&D Game

Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology p…

Read the full story

Wednesday, October 10, 2018

AlmirallShare Issues Call for Proposals

Almirall is seeking to find novel targets and concepts in the treatment of dermatological diseases. The company’s AlmirallShare open innovation platform is calling for proposals from Octobe…

Read the full story

Tuesday, October 09, 2018

Topix Pharmaceuticals Introduces Its New Backbar Line

Topix Pharmaceuticals, Inc. is rolling out its Backbar Line, a collection of 10 professional products that allows physicians to use their own branding. Only available for sale direct to office…

Read the full story

Tuesday, October 09, 2018

Alastin Skincare’s Latest Product May Become Body Contouring Procedures’ New BFF

Alastin Skincare, Inc. is launching TransFORM Body Treatment with TriHex Technology at the upcoming American Society for Dermatologic Surgery (ASDS) Annual Meeting in Phoenix. When t…

Read the full story

Tuesday, October 09, 2018

Online Care May Be As Effective as In-Person Care for Psoriasis

Teledermatology may be as effective as seeing a doctor in person when it comes to improving the symptoms of psoriasis, according to a new study in JAMA Network Open. “Patients with chronic sk…

Read the full story

Monday, October 08, 2018

Ortho Dermatologics Receives Tentative FDA Approval for Bryhali for Plaque Psoriasis

The FDA has provided tentative approval of the New Drug Application for Bryhali (halobetasol propionate) Lotion, 0.01%, for the topical treatment of plaque psoriasis in adult patients. Bryhali Lotion …

Read the full story

Friday, October 05, 2018

EPI Acquires Rights to Cloderm Cream from Promius Pharma

EPI Health has acquired the rights rights to Cloderm® (clocortolone pivalate) Cream, 0.1% and its authorized generic from Promius Pharma, LLC, a wholly owned subsidiary of D…

Read the full story
Load More